HRT Financial’s Achieve Life Sciences ACHV Stock Holding History

HRT Financial’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$92K	Buy	31,579 +12,721	+67%	+$56.5K	﹤0.01%	3365
2025 Q4	$93K	Buy	+18,858	New	+$82.2K	﹤0.01%	2797
2023 Q1	–	Sell	-13,031	Closed	-$32K	–	2412
2022 Q4	$32K	Buy	+13,031	New	+$33.4K	﹤0.01%	2138
2020 Q1	–	Sell	-539	Closed	-$5K	–	718
2019 Q4	$5K	Buy	+539	New	+$11.6K	﹤0.01%	1098

Other funds holding ACHV

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial's ACHV Position: Q1 2026 in Review

HRT Financial increased its Achieve Life Sciences (ACHV) stake by 67% in Q1 2026, buying an estimated $56.5K and bringing the position to 31,579 shares worth $92K. The position accounts for ﹤0.01% of the portfolio, ranked #3365.

HRT Financial first reported a position in ACHV in Q4 2019 and has held it in 4 quarters since. The position peaked at $93K in Q4 2025. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

HRT Financial held 31,579 shares of Achieve Life Sciences worth $92K as of Q1 2026.
HRT Financial bought 12,721 Achieve Life Sciences shares in Q1 2026, an estimated $56.5K.
Achieve Life Sciences made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3365 holding.
HRT Financial first reported a position in Achieve Life Sciences in Q4 2019 and has held it in 4 quarters since.
HRT Financial's Achieve Life Sciences position peaked at $93K in Q4 2025.
81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.